WST Income Statement
West Pharmaceutical Services Inc - Revenue, Expenses & Profit Analysis
Stock Price
$0.00
Market Cap
$15.97B
P/E Ratio
34.8
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$2.89B
-1.9% YoY
Net Income
Bottom line profit
$492.70M
Earnings Per Share (Diluted)
Net income per share
$6.69
Profitability Metrics
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $2.89B | - | - | $492.70M | $6.69 |
| 2023-12-31 | $2.95B | - | - | $593.40M | $7.88 |
| 2022-12-31 | $2.89B | - | - | $585.90M | $7.73 |
| 2021-12-31 | $2.83B | - | - | $661.80M | $8.67 |
| 2020-12-31 | $2.15B | - | - | $98.40M | $1.29 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is WST's revenue?
WST's most recent quarterly revenue was $2.89B, representing a decline of 1.9% year-over-year.
Is WST profitable?
WST reported a profit of $492.70M in the most recent quarter.
What is WST's operating income?
Operating income data is available in the income statement.
What is WST's earnings per share (EPS)?
WST reported diluted earnings per share of $6.69 in the most recent quarter.
What is WST's gross profit margin?
Gross margin data is available in the profitability metrics section.